At Anagram, we empower our people to ask the big questions and find the hard answers. We work hard, celebrate successes, and create a space where people can grow and do their best work. We're driven by curiosity and a deep commitment to our work, our colleagues, and the patients we serve. If that sounds like you, then join us. We offer competitive compensation and benefits and a workplace where innovation and excellence drive real progress in science and medicine.
Location: Natick, MA
Anagram Therapeutics is seeking an experienced analytical scientist to lead and execute method lifecycle management across its enzyme-based therapeutic platform. The role emphasizes deep, hands-on engagement with analytical methods, data integrity, and technical oversight of outsourced testing.
Location: Natick, MA
The Director of Bioprocessing MSAT is a key leadership position responsible for overseeing all Manufacturing Science and Technology (MSAT) activities across external biomanufacturing sites (CDMOs) for outsourced process development and GMP manufacturing.
Location: Natick, MA
The Director, Clinical Operations will be responsible for planning, implementing, executing and managing clinical studies. A large responsibility will be managing the daily operations of third party vendors in order to achieve project timelines and goals. The Director, Clinical Operations leads the execution and delivery of project activities related to a product or products.
Location: Natick, MA
The Head of Analytical Sciences will serve as the functional leader for all analytical development and control strategy efforts across Anagram Therapeutics' enzyme-based product platform. This role is critical to advancing product and process understanding across both drug substance and drug product, ensuring method robustness, driving phase-appropriate control strategies, and enabling regulatory and commercial success.
Location: Natick, MA
Anagram Therapeutics is seeking an accomplished, hands-on leader to serve as Head of Formulation Development, responsible for advancing our enzyme-based therapeutics into scalable, patient-friendly oral presentations. This role will lead formulation strategy and execution across drug substance and drug product interfaces.